ArticleDisease markers2021

MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.

Jin-Zhang Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.